8.6IVJan 27, 2025
Z-Stack Scanning can Improve AI Detection of Mitosis: A Case Study of MeningiomasHongyan Gu, Ellie Onstott, Wenzhong Yan et al.
Z-stack scanning is an emerging whole slide imaging technology that captures multiple focal planes alongside the z-axis of a glass slide. Because z-stacking can offer enhanced depth information compared to the single-layer whole slide imaging, this technology can be particularly useful in analyzing small-scaled histopathological patterns. However, its actual clinical impact remains debated with mixed results. To clarify this, we investigate the effect of z-stack scanning on artificial intelligence (AI) mitosis detection of meningiomas. With the same set of 22 Hematoxylin and Eosin meningioma glass slides scanned by three different digital pathology scanners, we tested the performance of three AI pipelines on both single-layer and z-stacked whole slide images (WSIs). Results showed that in all scanner-AI combinations, z-stacked WSIs significantly increased AI's sensitivity (+17.14%) on the mitosis detection with only a marginal impact on precision. Our findings provide quantitative evidence that highlights z-stack scanning as a promising technique for AI mitosis detection, paving the way for more reliable AI-assisted pathology workflows, which can ultimately benefit patient management.
5.1IVAug 29, 2025
Team Westwood Solution for MIDOG 2025 Challenge: An Ensemble-CNN-Based Approach For Mitosis Detection And ClassificationTengyou Xu, Haochen Yang, Xiang 'Anthony' Chen et al.
This abstract presents our solution (Team Westwood) for mitosis detection and atypical mitosis classification in the MItosis DOmain Generalization (MIDOG) 2025 challenge. For mitosis detection, we trained an nnUNetV2 for initial mitosis candidate screening with high sensitivity, followed by a random forest classifier ensembling predictions of three convolutional neural networks (CNNs): EfficientNet-b3, EfficientNet-b5, and EfficientNetV2-s. For the atypical mitosis classification, we trained another random forest classifier ensembling the predictions of three CNNs: EfficientNet-b3, EfficientNet-b5, and InceptionV3. On the preliminary test set, our solution achieved an F1 score of 0.7450 for track 1 mitosis detection, and a balanced accuracy of 0.8722 for track 2 atypical mitosis classification. On the final test set, our solution achieved an F1 score of 0.6972 for track 1 mitosis detection, and a balanced accuracy of 0.8242 for track 2 atypical mitosis classification.
3.3AIAug 28, 2025
Addressing accuracy and hallucination of LLMs in Alzheimer's disease research through knowledge graphsTingxuan Xu, Jiarui Feng, Justin Melendez et al.
In the past two years, large language model (LLM)-based chatbots, such as ChatGPT, have revolutionized various domains by enabling diverse task completion and question-answering capabilities. However, their application in scientific research remains constrained by challenges such as hallucinations, limited domain-specific knowledge, and lack of explainability or traceability for the response. Graph-based Retrieval-Augmented Generation (GraphRAG) has emerged as a promising approach to improving chatbot reliability by integrating domain-specific contextual information before response generation, addressing some limitations of standard LLMs. Despite its potential, there are only limited studies that evaluate GraphRAG on specific domains that require intensive knowledge, like Alzheimer's disease or other biomedical domains. In this paper, we assess the quality and traceability of two popular GraphRAG systems. We compile a database of 50 papers and 70 expert questions related to Alzheimer's disease, construct a GraphRAG knowledge base, and employ GPT-4o as the LLM for answering queries. We then compare the quality of responses generated by GraphRAG with those from a standard GPT-4o model. Additionally, we discuss and evaluate the traceability of several Retrieval-Augmented Generation (RAG) and GraphRAG systems. Finally, we provide an easy-to-use interface with a pre-built Alzheimer's disease database for researchers to test the performance of both standard RAG and GraphRAG.